Detalles de la búsqueda
1.
Multisensory integration in neurons of the medial pulvinar of macaque monkey.
Cereb Cortex
; 33(8): 4202-4215, 2023 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068947
2.
Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancer.
Br J Clin Pharmacol
; 88(1): 166-177, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087010
3.
Population pharmacokinetic model selection assisted by machine learning.
J Pharmacokinet Pharmacodyn
; 49(2): 257-270, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34708337
4.
Fast screening of covariates in population models empowered by machine learning.
J Pharmacokinet Pharmacodyn
; 48(4): 597-609, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019213
5.
Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non-small cell lung cancer based on bintrafusp alfa trials.
CPT Pharmacometrics Syst Pharmacol
; 13(1): 143-153, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087967
6.
Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials.
CPT Pharmacometrics Syst Pharmacol
; 12(8): 1157-1169, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37332136
7.
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug development.
CPT Pharmacometrics Syst Pharmacol
; 12(2): 180-195, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36350330
8.
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.
CPT Pharmacometrics Syst Pharmacol
; 12(11): 1738-1750, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37165943
9.
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging.
JCO Clin Cancer Inform
; 7: e2200126, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146261
10.
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.
CPT Pharmacometrics Syst Pharmacol
; 12(8): 1170-1181, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37328961
11.
Effects of contrast and contrast adaptation on static receptive field features in macaque area V1.
J Neurophysiol
; 108(7): 2033-50, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815398
12.
Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma.
Br J Clin Pharmacol
; 73(4): 597-605, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21999172
13.
Optimization of dose selection using multiple surrogates of toxicity as a continuous variable in phase I cancer trial.
Contemp Clin Trials
; 113: 106657, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34954097
14.
Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants.
Clin Transl Sci
; 15(12): 2899-2908, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36165192
15.
Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study.
Cancer Chemother Pharmacol
; 89(5): 655-669, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385993
16.
Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study.
Clin Transl Sci
; 15(12): 2888-2898, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126241
17.
Predicting disease activity in patients with multiple sclerosis: An explainable machine-learning approach in the Mavenclad trials.
CPT Pharmacometrics Syst Pharmacol
; 11(7): 843-853, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35521742
18.
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations.
Cancer Chemother Pharmacol
; 90(1): 53-69, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771259
19.
Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab.
Clin Cancer Res
; 28(7): 1363-1371, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921021
20.
Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model-based dose-toxicity models.
CPT Pharmacometrics Syst Pharmacol
; 11(10): 1371-1381, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35852048